TELA Bio (NASDAQ:TELA) just reported results for the second quarter of 2024.
- TELA Bio reported earnings per share of -51 cents. This was below the analyst estimate for EPS of -47 cents.
- The company reported revenue of $16.09 million.
- This was 12.83% worse than the analyst estimate for revenue of $18.46 million.